| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |